Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CRVL | Common Stock | Options Exercise | $81.1K | +2K | +1.66% | $40.57* | 122K | May 31, 2022 | Direct | |
transaction | CRVL | Common Stock | Sale | -$299K | -2K | -1.63% | $149.34 | 120K | May 31, 2022 | Direct | |
transaction | CRVL | Common Stock | Options Exercise | $40.6K | +1K | +0.83% | $40.57* | 121K | Jun 1, 2022 | Direct | |
transaction | CRVL | Common Stock | Sale | -$148K | -1K | -0.82% | $147.98 | 120K | Jun 1, 2022 | Direct | |
transaction | CRVL | Common Stock | Options Exercise | $34.8K | +1K | +0.83% | $34.77* | 121K | Jun 1, 2022 | Direct | |
transaction | CRVL | Common Stock | Sale | -$148K | -1K | -0.82% | $147.98 | 120K | Jun 1, 2022 | Direct | |
transaction | CRVL | Common Stock | Options Exercise | $69.5K | +2K | +1.66% | $34.77* | 122K | Jun 2, 2022 | Direct | |
transaction | CRVL | Common Stock | Sale | -$301K | -2K | -1.63% | $150.59 | 120K | Jun 2, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CRVL | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -1K | -33.33% | $0.00 | 2K | Jun 1, 2022 | Common Stock | 1K | $34.77 | Direct | F1 |
transaction | CRVL | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -2K | -100% | $0.00* | 0 | Jun 2, 2022 | Common Stock | 2K | $34.77 | Direct | F1 |
transaction | CRVL | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -2K | -66.67% | $0.00 | 1K | May 31, 2022 | Common Stock | 2K | $40.57 | Direct | F1 |
transaction | CRVL | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -1K | -100% | $0.00* | 0 | Jun 1, 2022 | Common Stock | 1K | $40.57 | Direct | F1 |
Id | Content |
---|---|
F1 | Exercisable in a series of 4 equal and successive annual installments commencing 12 months following the date of grant. |